The C1QTNF6 antibody targets the complement C1q/tumor necrosis factor-related protein 6 (C1QTNF6), a member of the CTRP family involved in metabolic regulation, inflammation, and immune response. C1QTNF6 is primarily secreted by adipose tissue and plays roles in glucose metabolism, insulin sensitivity, and energy homeostasis, with potential links to obesity, diabetes, and cardiovascular diseases. It also modulates osteogenic differentiation and bone remodeling, suggesting relevance in skeletal disorders. Antibodies against C1QTNF6 are utilized in research to study its expression patterns, interaction partners, and signaling pathways, particularly in metabolic and inflammatory contexts. Recent studies explore its dual role in cancer—acting as a tumor suppressor or promoter depending on the tissue type—highlighting its therapeutic or diagnostic potential. These antibodies enable detection via techniques like Western blot, ELISA, and immunohistochemistry, aiding mechanistic insights into C1QTNF6's physiological and pathological functions. However, its precise mechanisms remain under investigation, necessitating further validation of antibody specificity and functional studies.